Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Journal of Neurology
|
December 6, 2018
Recessive PYROXD1 mutations cause adult-onset limb-girdle-type muscular dystrophy
Markus T Sainio, Salla Välipakka, Bruno Rinaldi, et al.
Neurology. Genetics
|
May 16, 2019
Oligogenic basis of sporadic ALS: The example of <i>SOD1</i> p.Ala90Val mutation
Liina Kuuluvainen, Karri Kaivola, Saana Mönkäre, et al.
Neurology
|
March 8, 2019
An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy
Manu Jokela, Giorgio Tasca, Anna Vihola, et al.
Neuromuscular Disorders : NMD
|
January 21, 2020
Mutations in the J domain of DNAJB6 cause dominant distal myopathy
Johanna Palmio, Per Harald Jonson, Michio Inoue, et al.
Neurobiology of Disease
|
August 10, 2018
Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
Emmanuelle C Genin, Sylvie Bannwarth, Françoise Lespinasse, et al.
Human Molecular Genetics
|
January 10, 2018
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency
Sarah J Brockmann, Axel Freischmidt, Patrick Oeckl, et al.
Acta Neuropathologica
|
May 11, 2021
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions
Mridul Johari, Jaakko Sarparanta, Anna Vihola, et al.
Acta Neuropathologica Communications
|
May 21, 2025
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism
Sandra Harjuhaahto, Manu Jokela, Jayasimman Rajendran, et al.
Acta Neuropathologica Communications
|
December 17, 2022
NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy
Natasha Ranu, Jenni Laitila, Hannah F Dugdale, et al.
Scientific Reports
|
April 14, 2026
Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial
Michael Neumann, Hardik Kothare, Meredith Bartlett, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Journal of Neurology
|
December 6, 2018
Recessive PYROXD1 mutations cause adult-onset limb-girdle-type muscular dystrophy
Markus T Sainio, Salla Välipakka, Bruno Rinaldi, et al.
Neurology. Genetics
|
May 16, 2019
Oligogenic basis of sporadic ALS: The example of <i>SOD1</i> p.Ala90Val mutation
Liina Kuuluvainen, Karri Kaivola, Saana Mönkäre, et al.
Neurology
|
March 8, 2019
An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy
Manu Jokela, Giorgio Tasca, Anna Vihola, et al.
Neuromuscular Disorders : NMD
|
January 21, 2020
Mutations in the J domain of DNAJB6 cause dominant distal myopathy
Johanna Palmio, Per Harald Jonson, Michio Inoue, et al.
Neurobiology of Disease
|
August 10, 2018
Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases
Emmanuelle C Genin, Sylvie Bannwarth, Françoise Lespinasse, et al.
Human Molecular Genetics
|
January 10, 2018
CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency
Sarah J Brockmann, Axel Freischmidt, Patrick Oeckl, et al.
Acta Neuropathologica
|
May 11, 2021
Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions
Mridul Johari, Jaakko Sarparanta, Anna Vihola, et al.
Acta Neuropathologica Communications
|
May 21, 2025
Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism
Sandra Harjuhaahto, Manu Jokela, Jayasimman Rajendran, et al.
Acta Neuropathologica Communications
|
December 17, 2022
NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy
Natasha Ranu, Jenni Laitila, Hannah F Dugdale, et al.
Scientific Reports
|
April 14, 2026
Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial
Michael Neumann, Hardik Kothare, Meredith Bartlett, et al.
Page
of 5